Continence Rate and Oncological Feasibility after Total Transurethral Resection of the Prostate as an Alternative Therapy for the Treatment of Prostate Cancer: A Pilot Study

PURPOSE: The value of total transurethral resection of prostate cancer (TURPC) as an alternative therapy was first recognized by Hans J. Reuter. Thus, we conducted the study of prospectively collected data to verify total TURPC as an alternative therapy forlocalized prostate cancer. METHODS: From Ja...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Hee Jong, Kwon, Dong Deuk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Continence Society 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3256308/
https://www.ncbi.nlm.nih.gov/pubmed/22259737
http://dx.doi.org/10.5213/inj.2011.15.4.222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3256308/
https://www.ncbi.nlm.nih.gov/pubmed/22259737
http://dx.doi.org/10.5213/inj.2011.15.4.222

Ejemplares similares